BioCentriq and panCELLa execute research agreement to study stem cell-derived Natural Killer cell expansion technology

/PRNewswire/ -- BioCentriq, Inc. and panCELLa, a Pluristyx Company, announced that they have signed a research agreement designed to evaluate the ability of...

Related Keywords

South Korea ,Alex Klarer ,Mahendra Rao ,Prnewswire Biocentriq Inc ,Pluristyx Company ,Pluripotent Stem Cell ,Vice President ,Business Strategy ,Chief Scientific Officer ,New Jersey Based ,Highlander Factory Dba Biocentriq ,Biotechnology ,Health Care Amp Hospitals ,Medical Equipment ,Medical Pharmaceuticals ,Licensing ,